Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 61 to 75 of 141 results for copd

  1. Quality standards advisory committee members

    with University of Oxford focusing on asthma, idiopathic pulmonary fibrosis, COPD and mesothelioma working with top pharma companies....

  2. Sternal Talon for sternal closure in cardiothoracic surgery (MIB88)

    NICE has developed a medtech innovation briefing (MIB) on the Sternal Talon for sternal closure in cardiothoracic surgery .

    Medtech innovation briefing
    Published
    29 November 2016

  3. Air pollution: outdoor air quality and health (QS181)

    This quality standard covers road-traffic-related air pollution and its impact on health. It describes high-quality actions in priority areas for improvement.

    Quality standard
    Published
    28 February 2019
    View quality statements

    Sections for QS181

  4. Physical activity: exercise referral schemes (PH54)

    This guideline covers exercise referral schemes for people aged 19 and older, in particular, those who are inactive or sedentary. The aim is to encourage people to be physically active.

    Public health guideline
    Published
    24 September 2014
    View recommendations

    Sections for PH54

  5. superDimension Navigation System to help diagnostic sampling of peripheral lung lesions (MIB194)

    NICE has developed a medtech innovation briefing (MIB) on superDimension Navigation System to help diagnostic sampling of peripheral lung lesions .

    Medtech innovation briefing
    Published
    11 October 2019

  6. Virtual ward platform technologies for acute respiratory infections (HTE13)

    Early value assessment (EVA) guidance on virtual ward platform technologies for acute respiratory infections....

    Health technology evaluation
    Published
    12 October 2023
    View recommendations

    Sections for HTE13

  7. Heart failure: beta blockers (IND194)

    This indicator covers the percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM173

    General practice indicators suitable for use in QOF
    Last updated
    30 April 2020

  8. Astegolimab as add-on maintenance treatment for moderate to severe chronic obstructive pulmonary disease [ID6524]

    Awaiting development [GID-TA11663] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  9. Smart One for measuring lung function (MIB96)

    NICE has developed a medtech innovation briefing (MIB) on Smart One for measuring lung function .

    Medtech innovation briefing
    Published
    9 February 2017

  10. InterDry for intertrigo (MIB192)

    NICE has developed a medtech innovation briefing (MIB) on InterDry for intertrigo .

    Medtech innovation briefing
    Published
    10 September 2019

  11. What is the clinical effectiveness of continuous positive pressure ventilation compared with usual care in patients with community-acquired pneumonia and type I respiratory failure without a history of chronic obstructive pulmonary disease?

    pneumonia and type I respiratory failure without a history of chronic obstructive pulmonary disease? Any explanatory notes(if...

    Research recommendation
    Published
    9 June 2015

  12. RespiraSense for continuously monitoring respiratory rate (MIB299)

    NICE has developed a medtech innovation briefing (MIB) on RespiraSense for continuously monitoring respiratory rate .

    Medtech innovation briefing
    Published
    5 July 2022

  13. Artificial intelligence-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessment (HTE12)

    Early value assessment (EVA) guidance on artificial intelligence (AI)-derived software to analyse chest X-rays for suspected lung cancer in primary care referra...

    Health technology evaluation
    Published
    28 September 2023
    View recommendations

    Sections for HTE12

  14. What is the impact and longer-term clinical outcomes of adding procalcitonin testing to standard clinical practice with protocol-driven care in the NHS, to guide the use of antibiotic treatment in adults presenting to the emergency department with exacerbations of chronic inflammatory respiratory conditions such as chronic obstructive pulmonary disease?

    exacerbations of chronic inflammatory respiratory conditions such as chronic obstructive pulmonary disease? Any explanatory notes(if...

    Research recommendation
    Published
    12 January 2016

  15. Interventions to improve CPAP adherence: Which interventions, including behavioural interventions, are most clinically and cost effective to improve adherence to CPAP in people with OSAHS, obesity hypoventilation syndrome (OHS) and COPD–OSAHS (chronic obstructive pulmonary disease–OSAHS) overlap syndrome who have difficulty using CPAP?

    to CPAP in people with OSAHS, obesity hypoventilation syndrome (OHS) and COPD–OSAHS (chronic obstructive pulmonary disease–OSAHS)...

    Research recommendation
    Published
    30 September 2021